focus -WSS

focus

author：hotspot 2025-09-10 05:02:38 - browse：7622

Exact Sciences headquarters. -- biotech coverage from STAT — Exact Sciences' headquarters in Madison, Wis. Wikimedia Commons

Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection company’s executives still believe they’re on track to meet expected 2024 revenue.

That’s usually good news. Yet Exact shares are down nearly 11% on Thursday, dipping to $53.12 within the first few hours of trading. During after-hours trading on Wednesday, shortly after Exact released its financial updates, shares tumbled as low as $47.24.

The seemingly paradoxical result reflects worries about a potential slowdown in future growth at Exact, a $10 billion biotech best known for Cologuard, a colon cancer screening test that detects blood and DNA from stool samples. The test, which first won regulatory approval in 2014, was designed to boost cancer screening rates by providing a more convenient alternative to colonoscopies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Rise in cancer among younger people worries and puzzles doctors

WSS

Democrats decry new health bill for going easy on private equity

New Covid vaccine is recommended for everyone 6 months or older

Pig kidney works a record two months in donated body

The battle over 'scope creep' and who gets to be called 'doctor'

Dems pitch expanding Medicare power to negotiate drug prices

PEPFAR is under serious threat — and so is global health

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Hospitals consider fixing cancer drug shortages on their own

At least 13 dead in Texas as scorching temps continue

Truvian presents data for its desktop blood

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How doctors’ personal politics affect patients

Psychedelics group wrestles with new pharma identity

CDC Director Mandy Cohen on transparency, trust, and health

Drug repurposing or repositioning? The language matters

Biogen says it will cut costs by $700 million, slash 1,000 jobs

hotspot

How to make the FDA’s new prescription one

Telehealth for opioid use disorder is lifesaving

New Covid vaccine is recommended for everyone 6 months or older

What it's like to live with paralysis for one psychologist

Truvian presents data for its desktop blood

Biogen says it will cut costs by $700 million, slash 1,000 jobs

explore

hotspot

knowledge

knowledge